Cartalax 20mg

Comprehensive Laboratory Profile

The acquisition of high-fidelity, tissue-specific bio-regulators is paramount for institutional laboratories investigating musculoskeletal health and tissue regeneration. The Cartalax 20mg peptide is a highly specialized synthetic tetrapeptide (Ala-Glu-Asp-Phe) engineered for precision in-vitro analysis.

Synthesized in the USA to the highest industry standards, this compound delivers the absolute analytical accuracy required by modern research facilities. Utilizing the Cartalax 20mg peptide ensures your facility obtains definitive data free from the inconsistencies often found in lower-purity research materials.

Biochemical Profile: Epigenetic Bio-Regulator

Unlike peptides that interact primarily with cell-surface receptors, Cartalax 20mg functions as a targeted epigenetic bio-regulator. Its primary mechanism of action involves direct infiltration of the cell membrane and the nuclear envelope.

Once inside the nucleus, the active tetrapeptide sequence binds to specific promoter regions of DNA. This highly targeted binding mechanism induces chromatin uncoiling and stimulates the transcription of specific proteins necessary for the synthesis of collagen and the normalization of chondrocyte function.

Mechanism of Action

When introduced to in-vitro chondrocyte or osteoarticular cell cultures, the Cartalax 20mg peptide serves as a powerful stimulus for the extracellular matrix (ECM). Research methodologies often expose these cell lines to simulated degradative stress to mimic osteoarticular trauma.

In such conditions, the peptide facilitates the restoration of the cartilaginous matrix by stimulating the localized synthesis of structural proteins. By normalizing the metabolic environment of the chondrocytes, the peptide assists researchers in documenting the regenerative potential of these specific cellular lines.

Primary Research Applications

The specificity and stability of this bio-regulator make it a foundational tool for cartilage-focused and regenerative studies.

Current scientific literature utilizes the Cartalax 20mg compound primarily for:

• Chondrocyte Proliferation Assays: Mapping the kinetic response of cartilage-building cells in culture.

• Collagen Synthesis Studies: Evaluating the rate of protein transcription triggered by epigenetic bio-regulators.

• Osteoarticular Modeling: Establishing control data for cellular repair in simulated degradative environments.

• Tissue Longevity Assays: Using the Cartalax 20mg peptide to evaluate cellular response to aging and metabolic decline.

Purity and Quality Assurance

At Ion Peptides, we recognize that anomalous data from impure materials compromises research outcomes. Every batch of our Cartalax 20mg peptide is subjected to third-party analytical testing.

We utilize High-Performance Liquid Chromatography (HPLC) to verify a purity threshold of >99.0%. This ensures the complete isolation of the tetrapeptide from residual solvents or truncated sequences.

Furthermore, Mass Spectrometry (MS) is employed to verify the precise molecular weight. By securing your Cartalax 20mg supply through our USA synthesis network, you guarantee materials that meet the highest echelons of analytical compliance.

Storage and Reconstitution

The Cartalax 20mg vial is supplied as a lyophilized (freeze-dried) powder to ensure stability.

• Storage: Keep vials in a climate-controlled environment at or below -20°C. Protected from light and moisture, the powder remains stable for up to 36 months.

• Reconstitution: Utilize sterile bacteriostatic water.

  1. Allow the vial to reach room temperature before opening.

  2. Introduce the diluent slowly, letting it flow down the interior glass wall.

  3. Do not vortex or shake. Allow the Cartalax 20mg compound to dissolve via gentle, rotational swirling.

  4. Store reconstituted solution at 2°C to 8°C and utilize within standard laboratory protocol timelines.